- Corporate Officers - L
- Longenecker John P Phd
Insider Trading History of Longenecker John P Phd
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Longenecker John P Phd since 2008.
This trader's CIK number is 1288231.
At the time of last reporting, Longenecker John P Phd was the Director of Pacira Biosciences, Inc.. (stock ticker symbol PCRX).
Also see all insider trading activities at Pacira Biosciences, Inc..
Note that in the past
LONGENECKER JOHN P PHD also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Aileron Therapeutics Inc (ALRN) by Longenecker John P Phd
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2018 | ALRN | 10,000 | $24,500 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Pacira Biosciences, Inc. (PCRX) by Longenecker John P Phd
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2022 | PCRX | 0 | $0 | 7,000 | $502,145 | 7,000 | $75,670 |
| 2021 | PCRX | 0 | $0 | 5,000 | $361,300 | 5,000 | $69,900 |
| 2020 | PCRX | 0 | $0 | 0 | $0 | 3,736 | $6,014 |
| 2019 | PCRX | 0 | $0 | 1,300 | $59,971 | 4,000 | $6,440 |
| 2016 | PCRX | 300 | $19,964 | 0 | $0 | 0 | $0 |
| 2015 | PCRX | 0 | $0 | 3,000 | $285,840 | 3,000 | $89,700 |
| 2014 | PCRX | 0 | $0 | 6,500 | $484,824 | 6,500 | $123,625 |
| 2013 | PCRX | 0 | $0 | 6,500 | $230,008 | 6,500 | $10,465 |
Yearly summary of insider trading at Favrille Inc (FVRL) by Longenecker John P Phd
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2008 | FVRL | 0 | $0 | 172,060 | $3,981 | 0 | $0 |
Insider trading activities at 3 companies by Longenecker John P Phd:
1. Aileron Therapeutics Inc (ALRN)
2. Pacira Biosciences, Inc. (PCRX)
3. Favrille Inc (FVRL)
Table 1. Insider trading of Aileron Therapeutics Inc (ALRN) by Longenecker John P Phd
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2018-08-10 | ALRN | Buy | 10,000 | 2.45 | 24,500 |
Table 2. Insider trading of Pacira Biosciences, Inc. (PCRX) by Longenecker John P Phd
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2022-03-03 | PCRX | Sale | 7,000 | 71.73 | 502,145 |
| 2022-03-03 | PCRX | Option Ex | 7,000 | 10.81 | 75,670 |
| 2021-03-01 | PCRX | Sale | 5,000 | 72.26 | 361,300 |
| 2021-03-01 | PCRX | Option Ex | 5,000 | 13.98 | 69,900 |
| 2020-03-12 | PCRX | Option Ex | 3,736 | 1.61 | 6,014 |
| 2019-12-02 | PCRX | Option Ex | 4,000 | 1.61 | 6,440 |
| 2019-12-02 | PCRX | Sale | 1,300 | 46.13 | 59,971 |
| 2016-01-12 | PCRX | Buy | 300 | 66.55 | 19,964 |
| 2015-03-12 | PCRX | Sale | 3,000 | 95.28 | 285,840 |
| 2015-03-12 | PCRX | Option Ex | 3,000 | 29.90 | 89,700 |
| 2014-12-29 | PCRX | Option Ex | 1,000 | 29.90 | 29,900 |
| 2014-12-29 | PCRX | Sale | 1,000 | 93.32 | 93,320 |
| 2014-09-29 | PCRX | Option Ex | 1,000 | 29.90 | 29,900 |
| 2014-09-29 | PCRX | Sale | 1,000 | 96.40 | 96,400 |
| 2014-06-30 | PCRX | Option Ex | 1,000 | 29.90 | 29,900 |
| 2014-06-30 | PCRX | Sale | 1,000 | 91.60 | 91,600 |
| 2014-03-28 | PCRX | Option Ex | 1,000 | 29.90 | 29,900 |
| 2014-03-28 | PCRX | Sale | 1,000 | 64.63 | 64,629 |
| 2013-12-30 | PCRX | Sale | 2,500 | 55.55 | 138,875 |
| 2013-12-30 | PCRX | Option Ex | 2,500 | 1.61 | 4,025 |
| 2013-09-30 | PCRX | Sale | 2,500 | 46.74 | 116,850 |
| 2013-09-30 | PCRX | Option Ex | 2,500 | 1.61 | 4,025 |
| 2013-06-28 | PCRX | Option Ex | 2,000 | 1.61 | 3,220 |
| 2013-06-28 | PCRX | Sale | 2,000 | 28.09 | 56,178 |
| 2013-03-28 | PCRX | Option Ex | 2,000 | 1.61 | 3,220 |
| 2013-03-28 | PCRX | Sale | 2,000 | 28.49 | 56,980 |
Table 3. Insider trading of Favrille Inc (FVRL) by Longenecker John P Phd
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2008-12-11 | FVRL | Sale | 135,000 | .02 | 3,240 |
| 2008-12-12 | FVRL | Sale | 37,060 | .02 | 741 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Longenecker John P Phd
(Director of Pacira Biosciences, Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.